|
US 11,702,460 B2 |
|
| Peptides and combination of peptides for use in immunotherapy against various tumors |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); Harpreet Singh, Munich (DE); and Lea Stevermann, Tuebingen (DE) |
| Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Oct. 2, 2019, as Appl. No. 16/591,177. |
| Application 16/591,177 is a continuation of application No. 15/847,825, filed on Dec. 19, 2017, granted, now 10,501,522. |
| Application 15/847,825 is a continuation of application No. 15/789,771, filed on Oct. 20, 2017, granted, now 10,370,429, issued on Aug. 6, 2019. |
| Application 15/789,771 is a continuation of application No. 15/362,274, filed on Nov. 28, 2016, granted, now 9,840,548, issued on Dec. 12, 2017. |
| Application 15/362,274 is a continuation of application No. 15/083,075, filed on Mar. 28, 2016, granted, now 10,000,547, issued on Jun. 19, 2018. |
| Claims priority of provisional application 62/139,189, filed on Mar. 27, 2015. |
| Claims priority of application No. 1505305 (GB), filed on Mar. 27, 2015. |
| Prior Publication US 2020/0040060 A1, Feb. 6, 2020 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 7/00 (2006.01); C07K 14/74 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01); A01N 37/46 (2006.01); C07K 14/725 (2006.01); C12Q 1/6886 (2018.01); C07K 14/47 (2006.01); C07K 16/30 (2006.01); A61K 38/08 (2019.01); C07K 7/02 (2006.01); C07K 7/06 (2006.01); G01N 33/566 (2006.01); C07K 16/18 (2006.01); C12N 5/0783 (2010.01); C12N 9/64 (2006.01); C07K 14/00 (2006.01); A61K 38/17 (2006.01); G01N 33/50 (2006.01); A61K 38/06 (2006.01); A61K 38/00 (2006.01) |